Omeros | OMER - Pendapatan Penjualan





Penjualan Perubahan Tanggal
Adma Biologics USD 139.16M 4.94M 2025-12
Alnylam Pharmaceuticals USD 1.1B 150M 2025-12
BioMarin Pharmaceutical USD 875M 99M 2025-12
Cytokinetics USD 17.76M 15.83M 2025-12
Gilead Sciences USD 7.93B 130M 2025-12
Heron Therapeutics USD 40.59M 2.38M 2025-12
Insmed USD 263.8M 121.8M 2025-12
Knight Therapeutics CAD 133.11M 11.56M 2025-12
MacroGenics USD 41.23M 31.61M 2025-12
Pacira USD 196.87M 17.35M 2025-12
Pfizer USD 17.58B 880M 2025-12
Rockwell Medical USD 25.83M 3.15M 2024-06
Sangamo BioSciences USD 356K 125K 2024-06
Sarepta Therapeutics USD 442.9M 43.5M 2025-12
United Therapeutics USD 790.2M 9.3M 2025-12
Vertex Pharmaceuticals USD 3.19B 110M 2025-12
Xoma USD 25K 5M 2024-09